GB201721604D0 - An oral liquid pharmaceutical composition of lamotrigine` - Google Patents
An oral liquid pharmaceutical composition of lamotrigine`Info
- Publication number
- GB201721604D0 GB201721604D0 GBGB1721604.5A GB201721604A GB201721604D0 GB 201721604 D0 GB201721604 D0 GB 201721604D0 GB 201721604 A GB201721604 A GB 201721604A GB 201721604 D0 GB201721604 D0 GB 201721604D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- lamotrigine
- pharmaceutical composition
- oral liquid
- liquid pharmaceutical
- oral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Dispersion Chemistry (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1721604.5A GB2569615B (en) | 2017-12-21 | 2017-12-21 | An oral liquid pharmaceutical composition of lamotrigine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1721604.5A GB2569615B (en) | 2017-12-21 | 2017-12-21 | An oral liquid pharmaceutical composition of lamotrigine |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| GB201721604D0 true GB201721604D0 (en) | 2018-02-07 |
| GB2569615A GB2569615A (en) | 2019-06-26 |
| GB2569615B GB2569615B (en) | 2021-12-22 |
Family
ID=61131695
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1721604.5A Expired - Fee Related GB2569615B (en) | 2017-12-21 | 2017-12-21 | An oral liquid pharmaceutical composition of lamotrigine |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB2569615B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2628595A (en) * | 2023-03-29 | 2024-10-02 | Orbit Pharma Ltd | A biphasic liquid pharmaceutical composition of an anticonvulsant drug and the process of preparing the same |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009061513A1 (en) * | 2007-11-09 | 2009-05-14 | Thar Pharmaceuticals | Crystalline forms of lamotrigine |
| CN104873461A (en) * | 2015-06-24 | 2015-09-02 | 万特制药(海南)有限公司 | Preparation method for lamotrigine oral solution |
| WO2018071547A1 (en) * | 2016-10-11 | 2018-04-19 | Aucta Pharmaceuticals | Powder for oral suspension containing lamotrigine |
| WO2018142336A1 (en) * | 2017-02-03 | 2018-08-09 | Jubilant Generics Limited | Lamotrigine suspension dosage form |
-
2017
- 2017-12-21 GB GB1721604.5A patent/GB2569615B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| GB2569615A (en) | 2019-06-26 |
| GB2569615B (en) | 2021-12-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL279464A (en) | Pharmaceutical formulation of odevixibat | |
| IL258082B (en) | Bezimidazole derivatives and pharmaceutical compositions containing them | |
| PT3565550T (en) | Pharmaceutical compositions comprising meloxicam | |
| SMT202500036T1 (en) | Pharmaceutical compositions comprising meloxicam | |
| IL271657A (en) | Pharmaceutical compositions | |
| IL271986A (en) | Pharmaceutical composition | |
| ZA201802199B (en) | Pharmaceutical compositions of il-2 | |
| ZA201907313B (en) | Stable liquid pharmaceutical composition | |
| GB201712159D0 (en) | Pharmaceutical composition | |
| HUE068810T2 (en) | Pharmaceutical composition | |
| GB201705303D0 (en) | Pharmaceutical compositions | |
| IL272419A (en) | Pharmaceutical composition | |
| GB201719447D0 (en) | Pharmaceutical composition | |
| GB201713660D0 (en) | Pharmaceutical compositions | |
| GB201705305D0 (en) | Pharmaceutical compositions | |
| GB201705304D0 (en) | Pharmaceutical compositions | |
| PL3646867T3 (en) | Pharmaceutical composition | |
| GB201705306D0 (en) | Pharmaceutical compositions | |
| IL267279A (en) | Pharmaceutical formulations of suvorexant | |
| GB201718468D0 (en) | Stable liquid pharmaceutical compositions of bortezomb | |
| ZA201804588B (en) | Pharmaceutical formulations for the treatment of diabetes | |
| GB2569615B (en) | An oral liquid pharmaceutical composition of lamotrigine | |
| GB201714241D0 (en) | Pharmaceutical compositions for the treatment of proteinopathies | |
| GB201715881D0 (en) | New pharmaceutical compositions | |
| GB201715404D0 (en) | Pharmaceutical compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 20220322 |